- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Call
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Shabih Shakeel
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Mark Eaton
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marco Herold
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sant-Rayn Pasricha
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A new regulator of 'stemness' to create dendritic cell factories for immunotherapy
- Advanced imaging interrogation of pathogen induced NETosis
- Cancer driver deserts
- Cryo-electron microscopy of Wnt signalling complexes
- Deciphering the heterogeneity of breast cancer at the epigenetic and genetic levels
- Developing drugs to block malaria transmission
- Developing new computational tools for CRISPR genomics to advance cancer research
- Developing novel antibody-based methods for regulating apoptotic cell death
- Discovering novel paradigms to cure viral and bacterial infections
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Do membrane forces govern assembly of the deadly apoptotic pore?
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- E3 ubiquitin ligases in neurodegeneration, autoinflammation and cancer
- Engineering improved CAR-T cell therapies
- Epigenetic biomarkers of tuberculosis infection
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- Genomic rearrangement detection with third generation sequencing technology
- How does DNA damage shape disease susceptibility over a lifetime?
- How does DNA hypermutation shape the development of solid tumours?
- How platelets prevent neonatal stroke
- Human lung protective immunity to tuberculosis
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of dysregulated Tom40 in neurodegeneration
- Investigating the role of mutant p53 in cancer
- Lupus: proteasome inhibitors and inflammation
- Machine learning methods for somatic genome rearrangement detection
- Malaria: going bananas for sex
- Measurements of malaria parasite and erythrocyte membrane interactions using cutting-edge microscopy
- Measuring susceptibility of cancer cells to BH3-mimetics
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Mutational signatures of structural variation
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Revealing the epigenetic origins of immune disease
- Reversing antimalarial resistance in human malaria parasites
- Structural and functional analysis of DNA repair complexes
- Targeting human infective coronaviruses using alpaca antibodies
- Towards targeting altered glial biology in high-grade brain cancers
- Uncovering the real impact of persistent malaria infections
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding how malaria parasites sabotage acquisition of immunity
- Understanding malaria infection dynamics
- Understanding the mechanism of type I cytokine receptor activation
- Unveiling the heterogeneity of small cell lung cancer
- Using alpaca antibodies to understand malaria invasion and transmission
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to cross the blood brain barrier for drug delivery
- Using structural biology to understand programmed cell death
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Sebastian Carotta
Sebastian Carotta … the gin scientist
Meet alumnus Sebastian Carotta, who leads a research team within the Cancer Research and Cancer Immunology Department at Boehringer Ingelheim in Vienna.
starting out with the distillation process.
Sebastian moved to Melbourne in 2004, describing the experience as “exciting but also frightening to move to the other side of the world”, and joined Professor Stephen Nutt’s lab at WEHI as a post doc, working on the transcriptional regulation of B, T and NK cell lineage commitment.
Although his immunology knowledge before starting in Stephen’s lab was rudimentary, he quickly got up to speed and started to love the immune system. “The training I received in Steve’s lab and in the immunology department is the reason I’m now working in cancer immunotherapy, and it’s where I think the future of successful cancer therapies lie,” he explains.
In 2011, Sebastian had the opportunity to run his own lab at WEHI. “Suddenly being responsible for directing the research of my own group was a delicate balance between asking big important questions while also delivering results quickly to be competitive for funding. It was an exciting and sometimes also a tough journey.”
The father of modern haematology
Sebastian recalls that one of his highlights at WEHI was working with Professor Don Metcalf, regarded as the ‘father of modern haematology’. “His vast experience and especially his love and dedication to science, still coming to the lab every day to perform his experiments, his willingness to talk to us about science all the time, this I will always remember.”
Another was the ‘bed to bench’ initiative that Professor Doug Hilton had organised, where WEHI scientists would tag alongside oncologists at the Royal Melbourne Hospital for a week. “Seeing the human aspect of cancer when we went on the rounds was transformative. This one week changed the focus of my research and I decided that I would move from basic science to translational science,” he says.
After departing WEHI eight years ago, Sebastian moved back to Vienna to lead a research team at Boehringer Ingelheim. In 2017, he started research on a novel cancer immunotherapy target, which entered Phase I clinical trials last year.
“A moment I will never forget is a meeting with the oncologists running our Phase I trial and seeing the first positive response data, the shrinkage of a treated tumour in a patient. There is still a long way to go for possible approval, but knowing our work at least made some difference to one cancer patient drives me to work harder on better therapies,” says Sebastian.
This year Sebastian was promoted to the role of Senior Scientific Director in the Cancer Research Department, tasked with researching emerging areas that could become the next wave of cancer immunotherapies. His main focus is to investigate the interaction between cancer cells and immune cells – specifically the effect that targeted therapies have not only on cancer cells but the tumour microenvironment; and identifying novel targets that induce immunogenic cell death in cancer cells.
Somehow Sebastian also finds time for another passion: gin. After four years and more than 200 experiments, he created two pretty special varieties and founded The Scientist Gin in May last year.
From beans to berries
“It started with Melbourne’s coffee scene where I met several coffee roaster friends,” he explains.
“I really admired their scientific approach to roasting – testing so many parameters and writing in their ‘coffee lab books’. Back in Vienna I travelled to London to buy my own coffee roaster, playing with the idea of opening my own coffee company – a Melbourne-style third wave cafe.
“While in London I also visited a famous gin distillery and did a one-day gin making workshop. So I went home with a coffee roaster and a distil. In the end, gin won!”
Sebastian is passionate about experimenting with rare botanicals that only grow in specific regions of the world. “Most of the time my experiments fail, but every now and then you find ‘the one’, it’s a fabulous experience.” In addition, The Scientist Gin is experimenting with fusion gins combining the specific flavours of different spirits with the characteristics of gin. In spring they will launch their new summer drink “LemonGINello” and “AranGINello”, a combination of their gins with their own handmade Limoncello and Arancello.
It took more than a year to produce two signature gins, working with the basic ingredients juniper, angelica and orris root, and carefully weighing the flavour profiles, often with the help of friends, in blind tastings of individual test series. Around 700 of the two varieties of gin have already been sold and are in circulation in his hometown of Baden, about a 40-minute drive from Vienna.
released a Stay Safe Pack, with three signature gins
and a bonus hand sanitizer made in strict accordance
to the WHO protocol.
During COVID, The Scientist Gin released a Stay Safe Pack, with three signature gins and a bonus hand sanitizer made in strict accordance to the WHO protocol.
It’s an exciting time for Sebastian and his business partner. Their new bottles are due to arrive soon and are inspired by Erlenmayer flasks. “Hopefully the company makes enough profit soon so that I can go on discovery expeditions to remote regions and try botanicals specific to that region. With gin, you can truly highlight the wonderful varieties that nature gives us,” he explains.
While The Scientist Gin focuses on the European market, Sebastian is hoping to expand soon to other regions.
- Connect with Sebastian on LinkedIn
- Visit the Scientist Gin website